NovoCure Limited(NASDAQ:NVCR) 
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients wit...
Website: https://www.novocure.com/
Founded: 2000
Full Time Employees: 782
CEO: Asaf Danziger
Sector: Healthcare
Industry: Medical Instruments & Supplies
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 16.25
H 16.80
L 15.92
C 16.49
V 985,364
10EMA 16.49
20EMA 16.49
60EMA 16.49
120EMA 16.49
250EMA 16.49